Ignite Creation Date:
2024-05-06 @ 2:14 AM
Last Modification Date:
2024-10-26 @ 11:15 AM
Study NCT ID:
NCT01997203
Status:
TERMINATED
Last Update Posted:
2013-11-28
First Post:
2013-11-19
Brief Title:
Long Term Vitamin D Therapy in HCV Treated Patients
Sponsor:
Dr Nadia AbdelAaty AbdelKader
Organization:
Ain Shams University
Study Overview
Official Title:
Effect of Long-term Vitamin D Therapy on IL-6 Visfatin and Hyaluronic Acid in Hepatitis C Virus Patients Assessment
Status:
TERMINATED
Status Verified Date:
2013-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
complete patients samples required
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VD-HCV
Brief Summary:
Treatment of hepatitis C virus HCV infection was carried out using pegylated interferon PEG-IFN ribavirin RBV and vitamin D vit D for 48 weeks in HCV genotypes 4a subjects The purpose of this study is to determine the effect of vitamin D on liver affection in such patients
Detailed Description:
Fifty patients study group administered vit D were compared with 50 patients control group without vit D The results showed a significant elevation in vit D levels during the time period and significant reduction on HCV RNA from the 12th wk to reach zero level in 24th wk Interleukin 6 IL-6 visfatin and hyaluronic acid levels were reduced significantly to reach normal values These concentrations reduction by the effect of vit D on HCV indicated the reduction in inflammation infection and liver cirrhosis and nearly amelioration HCV
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None